PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 61 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -55.6% | 2,800 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $9,000 | -10.0% | 2,800 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $10,000 | 0.0% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $10,000 | +11.1% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | -10.0% | 2,800 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $10,000 | -23.1% | 2,800 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $13,000 | +44.4% | 2,800 | 0.0% | 0.01% | -36.4% |
| Q1 2020 | $9,000 | -25.0% | 2,800 | 0.0% | 0.01% | +37.5% |
| Q3 2019 | $12,000 | -67.6% | 2,800 | 0.0% | 0.01% | -68.0% |
| Q2 2019 | $37,000 | – | 2,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|